[HTML][HTML] Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms

R Zhu, T Yan, Y Feng, Y Liu, H Cao, G Peng, Y Yang… - Cell research, 2021 - nature.com
The infusion of coronavirus disease 2019 (COVID-19) patients with mesenchymal stem cells
(MSCs) potentially improves clinical symptoms, but the underlying mechanism remains …

[HTML][HTML] Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside

LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - ncbi.nlm.nih.gov
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …

[HTML][HTML] Salidroside attenuates acute lung injury via inhibition of inflammatory cytokine production

D Song, M Zhao, L Feng, P Wang, Y Li, W Li - Biomedicine & …, 2021 - Elsevier
Acute lung injury is a fatal condition characterized by excessive inflammation responses.
Salidroside, the active constituent of Rhodiola rosea, possesses properties including anti …

Hypaphorine exerts anti‐inflammatory effects in sepsis induced acute lung injury via modulating DUSP1/p38/JNK pathway

YH Ding, RX Miao, Q Zhang - The Kaohsiung journal of …, 2021 - Wiley Online Library
Sepsis is a systemic inflammatory response syndrome attributed to infection, while sepsis‐
induced acute lung injury (ALI) has high morbidity and mortality. Here, we aimed to explore …

[HTML][HTML] Extracellular CIRP-impaired Rab26 restrains EPOR-mediated macrophage polarization in acute lung injury

W Zhang, Y Wang, C Li, Y Xu, X Wang, D Wu… - Frontiers in …, 2021 - frontiersin.org
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a condition with an
imbalanced inflammatory response and delayed resolution of inflammation. Macrophage …

Inhaled [D‐Ala2]‐Dynorphin 1‐6 Prevents Hyperacetylation and Release of High Mobility Group Box 1 in a Mouse Model of Acute Lung Injury

VN Karkischenko, VI Skvortsova… - Journal of …, 2021 - Wiley Online Library
COVID‐19 is a respiratory infection caused by the SARS‐CoV‐2 virus that can rapidly
escalate to life‐threatening pneumonia and acute respiratory distress syndrome (ARDS) …

Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the FSTL1 signaling pathway via increasing miR-200b-3p expression

X Duan, Y Sun, Z Zhao, Y Shi, X Ma, L Tao… - Innate …, 2021 - journals.sagepub.com
In China, baicalin is the main active component of Scutellaria baicalensis, which has been
used in the treatment of inflammation-related diseases, such as inflammation-induced acute …

[HTML][HTML] Natural molecule Munronoid I attenuates LPS-induced acute lung injury by promoting the K48-linked ubiquitination and degradation of TAK1

X Ma, X Li, Q Di, X Zhao, R Zhang, Y Xiao, P Sun… - Biomedicine & …, 2021 - Elsevier
Acute lung injury (ALI) is a severe lung disease with limited therapeutic strategies.
Munronoid I, a limonoid, which is extracted and purified from Munronia sinica, exhibits …

[HTML][HTML] The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019

R Huang, T Meng, Q Zha, K Cheng, X Zhou, J Zheng… - Critical Care, 2021 - Springer
Background The coronavirus disease 2019 (COVID-19) has induced a worldwide
epidemiological event with a high infectivity and mortality. However, the predicting …

[PDF][PDF] 微小RNA-155 在急性呼吸窘迫综合征中的研究进展

张丹萍, 陈建荣, 陈金亮, 张冬梅 - 临床急诊杂志, 2021 - lcjzen.whuhzzs.com
微小RNA-155在急性呼吸窘迫综合征中的研究进展 Page 1 临床急诊杂志 2021年
JournalofClinicalEmergency(China) 22卷12期 ·综述· 微小RNA-155在急性呼吸窘迫综合征中 …